Canaan Ix L.p. - Net Worth and Insider Trading
Canaan Ix L.p. Net Worth
The estimated net worth of Canaan Ix L.p. is at least $4 Million dollars as of 2024-09-20. Canaan Ix L.p. is the Director of CytomX Therapeutics Inc and owns about 3,244,381 shares of CytomX Therapeutics Inc (CTMX) stock worth over $4 Million. Details can be seen in Canaan Ix L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Canaan Ix L.p. has not made any transactions after 2016-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Canaan Ix L.p.
Canaan Ix L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Canaan Ix L.p. owns 3 companies in total, including Arvinas Inc (ARVN) , The RealReal Inc (REAL) , and CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Canaan Ix L.p.’s form 4 insider trades.
Insider Ownership Summary of Canaan Ix L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARVN | Arvinas Inc | 2018-09-26 | 10 percent owner |
| REAL | The RealReal Inc | 2019-06-27 | 10 percent owner |
| CTMX | CytomX Therapeutics Inc | 2016-11-29 | director & 10 percent owner |
Canaan Ix L.p. Latest Holdings Summary
Canaan Ix L.p. currently owns a total of 1 stock. Canaan Ix L.p. owns 3,244,381 shares of CytomX Therapeutics Inc (CTMX) as of November 29, 2016, with a value of $4 Million.
Latest Holdings of Canaan Ix L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2016-11-29 | 3,244,381 | 1.17 | 3,795,926 |
Holding Weightings of Canaan Ix L.p.
Canaan Ix L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Canaan Ix L.p. has made a total of 0 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years. The most-recent trade in CytomX Therapeutics Inc is the sale of 22,086 shares on November 29, 2016, which brought Canaan Ix L.p. around $246,921.
Insider Trading History of Canaan Ix L.p.
- 1
Canaan Ix L.p. Trading Performance
Canaan Ix L.p. Ownership Network
Canaan Ix L.p. Owned Company Details
What does Arvinas Inc do?
Who are the key executives at Arvinas Inc?
Canaan Ix L.p. is the 10 percent owner of Arvinas Inc. Other key executives at Arvinas Inc include Chief Medical Officer Ronald Peck , Chief Financial Officer Sean A Cassidy , and director & President and CEO John G Houston .
Arvinas Inc (ARVN) Insider Trades Summary
Over the past 18 months, Canaan Ix L.p. made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 3,023 shares made by Ronald Peck , a net sale of 5,196 shares made by John G Houston , and a net sale of 1,702 shares made by Sean A Cassidy .
In summary, during the past 3 months, insiders sold 0 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,622 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,622 shares.
Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arvinas Inc Insider Transactions
Canaan Ix L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Canaan Ix L.p.. You might contact Canaan Ix L.p. via mailing address: 2765 Sand Hill Road, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
